1. Home
  2. TURN vs AKTX Comparison

TURN vs AKTX Comparison

Compare TURN & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TURN
  • AKTX
  • Stock Information
  • Founded
  • TURN 1981
  • AKTX N/A
  • Country
  • TURN United States
  • AKTX United States
  • Employees
  • TURN N/A
  • AKTX N/A
  • Industry
  • TURN Finance/Investors Services
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TURN Finance
  • AKTX Health Care
  • Exchange
  • TURN Nasdaq
  • AKTX Nasdaq
  • Market Cap
  • TURN 39.6M
  • AKTX 32.8M
  • IPO Year
  • TURN N/A
  • AKTX N/A
  • Fundamental
  • Price
  • TURN $3.98
  • AKTX $1.10
  • Analyst Decision
  • TURN
  • AKTX
  • Analyst Count
  • TURN 0
  • AKTX 0
  • Target Price
  • TURN N/A
  • AKTX N/A
  • AVG Volume (30 Days)
  • TURN 46.0K
  • AKTX 26.0K
  • Earning Date
  • TURN 02-18-2025
  • AKTX 02-15-2025
  • Dividend Yield
  • TURN N/A
  • AKTX N/A
  • EPS Growth
  • TURN N/A
  • AKTX N/A
  • EPS
  • TURN N/A
  • AKTX N/A
  • Revenue
  • TURN $129,297.00
  • AKTX N/A
  • Revenue This Year
  • TURN N/A
  • AKTX N/A
  • Revenue Next Year
  • TURN N/A
  • AKTX N/A
  • P/E Ratio
  • TURN N/A
  • AKTX N/A
  • Revenue Growth
  • TURN 6.32
  • AKTX N/A
  • 52 Week Low
  • TURN $3.12
  • AKTX $0.90
  • 52 Week High
  • TURN $4.47
  • AKTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • TURN 55.71
  • AKTX 43.41
  • Support Level
  • TURN $3.78
  • AKTX $1.10
  • Resistance Level
  • TURN $4.05
  • AKTX $1.35
  • Average True Range (ATR)
  • TURN 0.14
  • AKTX 0.16
  • MACD
  • TURN -0.01
  • AKTX -0.01
  • Stochastic Oscillator
  • TURN 65.20
  • AKTX 9.23

About TURN 180 Degree Capital Corp.

180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Share on Social Networks: